Management of male breast cancer
AbstractThe management of male breast cancer is still under discussion due to lack of information from prospective, randomized clinical trials and low incidence of this disease. Current management is based largely on extrapolation from data related to treatment of female breast cancer. Over the last two decades, several review articles have discussed mainly retrospective and anecdotal data related to hormonal and chemotherapy treatment modalities. In this review, we present the most recent information and future considerations related to the management of male breast cancer. In addition to the conventional treatment options we will discuss the possible role of targeted therapy. Establishing a national or global registry for male breast cancer will provide more precise information about the natural history of the disease and will facilitate the design and execution of prospective, randomized multicenter clinical trials.
FULL TEXT: 237
Copyright (c) 2011 Nikolay V. Dimitro v, Sunil Nagpal, Shalini Chitneni
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.